,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2019_Mouse,PI3K-Akt signaling pathway,21/357,4.001018553537541e-05,0.0094137946397989,0,0,2.9029287439613527,29.396149407872883,ATF2;LAMA5;FLT1;RPS6;LPAR1;TSC1;RELN;CDK6;CCNE2;RHEB;GNB1;KDR;GNB4;PKN2;ITGAV;ITGA6;RAC1;TEK;EIF4E;JAK1;MCL1
1,KEGG_2019_Mouse,Cell cycle,11/123,7.877652418241765e-05,0.0094137946397989,0,0,4.506043632075472,42.57713549684343,CDC20;CDK6;PCNA;CCNE2;ORC1;E2F1;E2F2;E2F5;CDC14A;ANAPC1;CDC25B
2,KEGG_2019_Mouse,Focal adhesion,14/199,0.00012249183540051536,0.009758516220241,0,0,3.483597611863645,31.37838767356408,VAV3;LAMA5;FLT1;ACTB;VAV2;CDC42;RELN;KDR;RAPGEF1;ITGAV;ITGA6;RAC1;TLN1;MYL9
3,KEGG_2019_Mouse,Nitrogen metabolism,4/17,0.000419505850395762,0.023716931714852,0,0,13.958236658932714,108.54529337727315,CAR2;CAR1;CAR14;CAR8
4,KEGG_2019_Mouse,Human cytomegalovirus infection,15/255,0.0004961701195575742,0.023716931714852,0,0,2.8757440476190474,21.880362312357494,PDIA3;ATF2;TSC1;GNAI1;CDK6;RHEB;GNB1;GNA12;GNB4;E2F1;E2F2;ITGAV;RAC1;B2M;JAK1
5,KEGG_2019_Mouse,Pathways in cancer,24/535,0.0007130894436304304,0.0259990685376299,0,0,2.1773822617738228,15.777102183702262,LAMA5;TPM3;NCOA3;LEF1;LPAR1;SLC2A1;GNAI1;TGFBR1;CDC42;BMP2;CDK6;CCNE2;GNB1;GNA12;E2F1;GNB4;E2F2;ITGA6;ITGAV;RAC1;GSTM5;JAK1;NFE2L2;RUNX1T1
6,KEGG_2019_Mouse,Cellular senescence,12/185,0.0007614789948259819,0.0259990685376299,0,0,3.179928668060509,22.832676363441177,CDK6;CCNE2;RBBP4;RHEB;E2F1;E2F2;TSC1;TRPM7;MYBL2;E2F5;PPID;TGFBR1
7,KEGG_2019_Mouse,Adherens junction,7/72,0.0009569673921675352,0.0285894008410051,0,0,4.906542056074766,34.10901075731354,CDC42;LEF1;RAC1;WASF2;PTPRF;ACTB;TGFBR1
8,KEGG_2019_Mouse,Pancreatic cancer,7/75,0.0012196493427778,0.0323884658804328,0,0,4.689355415063222,31.461785298985344,CDC42;CDK6;E2F1;E2F2;RAC1;TGFBR1;JAK1
9,KEGG_2019_Mouse,ECM-receptor interaction,7/83,0.0022003085090203,0.052587373365587,0,0,4.194017461878997,25.663854233529968,LAMA5;RELN;ITGAV;ITGA6;AGRN;HSPG2;CD44
10,KEGG_2019_Mouse,Fc gamma R-mediated phagocytosis,7/87,0.0028762563270645,0.0624932056516758,0,0,3.9834988317757007,23.30851014750278,VAV3;CDC42;MARCKSL1;RAC1;PLPP3;WASF2;VAV2
11,KEGG_2019_Mouse,Insulin signaling pathway,9/139,0.0034188217727065,0.0650795852131129,0,0,3.158450704225352,17.93513376921898,PRKCI;PKLR;RHEB;RPS6;RAPGEF1;TSC1;PRKAB1;EIF4E;PTPRF
12,KEGG_2019_Mouse,Leukocyte transendothelial migration,8/115,0.0036663302342426,0.0650795852131129,0,0,3.407034515966644,19.108571314803957,VAV3;CDC42;PTPN11;RAC1;MYL9;ACTB;GNAI1;VAV2
13,KEGG_2019_Mouse,Small cell lung cancer,7/92,0.0039325664986446,0.0650795852131129,0,0,3.748213304013194,20.759340749700456,LAMA5;CDK6;CCNE2;E2F1;E2F2;ITGAV;ITGA6
14,KEGG_2019_Mouse,Hepatocellular carcinoma,10/171,0.0043221471689818,0.0650795852131129,0,0,2.8358056265984657,15.43813425453055,CDK6;ACTL6A;LEF1;E2F1;E2F2;ARID1A;ACTB;TGFBR1;GSTM5;NFE2L2
15,KEGG_2019_Mouse,cGMP-PKG signaling pathway,10/172,0.0045026148260658,0.0650795852131129,0,0,2.818155410312273,15.226766982412965,ATF2;GUCY1A1;GNA12;ATP2A2;GTF2IRD1;PDE5A;MYL9;MEF2D;GNAI1;GTF2I
16,KEGG_2019_Mouse,Thermogenesis,12/231,0.0048472601649465,0.0650795852131129,0,0,2.5060397033582693,13.355541762901986,ATF2;KDM1A;RHEB;NDUFAF4;RPS6KA1;ACTL6A;RPS6;COX17;TSC1;ARID1A;PRKAB1;ACTB
17,KEGG_2019_Mouse,beta-Alanine metabolism,4/32,0.0049013913549624,0.0650795852131129,0,0,6.475638051044084,34.43897246919874,SMOX;GAD2;ACADM;SRM
18,KEGG_2019_Mouse,Rap1 signaling pathway,11/209,0.0062261175908015,0.0783180054842931,0,0,2.537604821802935,12.8885007773999,CDC42;PRKCI;FLT1;KDR;LPAR1;RAPGEF1;RAC1;TEK;TLN1;ACTB;GNAI1
19,KEGG_2019_Mouse,Regulation of actin cytoskeleton,11/217,0.008161499860365,0.0975299233313621,0,0,2.4380495511998537,11.72294026571623,VAV3;CDC42;GNA12;LPAR1;ITGAV;ITGA6;RAC1;MYL9;WASF2;ACTB;VAV2
20,KEGG_2019_Mouse,Protein processing in endoplasmic reticulum,9/163,0.0094989588742474,0.1081071986164348,0,0,2.662932138284251,12.400138105182068,PDIA3;DNAJA1;HSPH1;HSPA5;UBE2D3;SSR3;MAN1C1;RRBP1;NFE2L2
21,KEGG_2019_Mouse,Insulin resistance,7/110,0.0102665564174472,0.1110396849796441,0,0,3.0903275564830777,14.150188410794764,RPS6KA1;SLC2A1;PRKCQ;TRIB3;PTPN11;PRKAB1;PTPRF
22,KEGG_2019_Mouse,Apelin signaling pathway,8/138,0.0107226744736351,0.1110396849796441,0,0,2.800936768149883,12.703353689203064,RPS6;GNB1;APLNR;GNB4;PRKAB1;MEF2D;TGFBR1;GNAI1
23,KEGG_2019_Mouse,Hypertrophic cardiomyopathy (HCM),6/86,0.0111504286172027,0.1110396849796441,0,0,3.406468531468532,15.316427270224665,TPM3;ATP2A2;ITGAV;ITGA6;PRKAB1;ACTB
24,KEGG_2019_Mouse,Thyroid hormone signaling pathway,7/115,0.0129016945617814,0.1173143514231334,0,0,2.9464996538594668,12.818442119845976,RHEB;NCOA3;SLC2A1;ATP2A2;ITGAV;ACTB;MED12L
25,KEGG_2019_Mouse,Fluid shear stress and atherosclerosis,8/143,0.013090733493711,0.1173143514231334,0,0,2.69650446699627,11.691640689015022,KDR;ITGAV;RAC1;ARHGEF2;ACTB;ASS1;GSTM5;NFE2L2
26,KEGG_2019_Mouse,Proteoglycans in cancer,10/203,0.0136895898930046,0.1173143514231334,0,0,2.36171898811338,10.134418632060726,CDC42;RPS6;KDR;ITGAV;PTPN11;RAC1;HSPG2;ACTB;CD44;VAV2
27,KEGG_2019_Mouse,GABAergic synapse,6/90,0.0137439407525009,0.1173143514231334,0,0,3.243589743589744,13.905779202673385,SLC32A1;GABRA4;GNB1;GNB4;GAD2;GNAI1
28,KEGG_2019_Mouse,Renal cell carcinoma,5/68,0.0161740812093887,0.1332967382428936,0,0,3.599483204134367,14.84551143144484,CDC42;SLC2A1;RAPGEF1;PTPN11;RAC1
29,KEGG_2019_Mouse,Human T-cell leukemia virus 1 infection,11/245,0.0187736642750674,0.1495635253913703,0,0,2.143212788259958,8.51991428510959,CDC20;ATF2;CCNE2;SLC2A1;E2F1;E2F2;TLN1;B2M;ANAPC1;TGFBR1;JAK1
30,KEGG_2019_Mouse,Arrhythmogenic right ventricular cardiomyopathy (ARVC),5/72,0.0202464386877874,0.1512155889494124,0,0,3.383894481082957,13.19643172969401,LEF1;ATP2A2;ITGAV;ITGA6;ACTB
31,KEGG_2019_Mouse,B cell receptor signaling pathway,5/72,0.0202464386877874,0.1512155889494124,0,0,3.383894481082957,13.19643172969401,VAV3;DAPP1;RAC1;BCL10;VAV2
32,KEGG_2019_Mouse,Choline metabolism in cancer,6/99,0.0210591068788877,0.1525189861834596,0,0,2.9283404767275734,11.30463053159366,RHEB;TSC1;RAC1;PLPP3;DGKZ;WASF2
33,KEGG_2019_Mouse,Bacterial invasion of epithelial cells,5/74,0.022512636527657,0.1528196447453545,0,0,3.285473542298618,12.46403035278624,CDC42;CLTA;RAC1;WASF2;ACTB
34,KEGG_2019_Mouse,Cysteine and methionine metabolism,4/50,0.0231496209517102,0.1528196447453545,0,0,3.9380611318470695,14.82985953146262,MTAP;DNMT3B;GCLM;SRM
35,KEGG_2019_Mouse,Cushing syndrome,8/159,0.023236609281928,0.1528196447453545,0,0,2.4087969353412846,9.061957320298372,HSD3B6;ATF2;CDK6;CCNE2;LEF1;E2F1;E2F2;GNAI1
36,KEGG_2019_Mouse,Autophagy,7/130,0.0236787622969573,0.1528196447453545,0,0,2.585175898487957,9.676770287368477,SH3GLB1;STX17;RHEB;RRAGD;TSC1;PRKCQ;HMGB1
37,KEGG_2019_Mouse,Fatty acid elongation,3/29,0.0245637023130888,0.1528196447453545,0,0,5.21875,19.343220897396208,ACOT7;ELOVL6;HSD17B12
38,KEGG_2019_Mouse,Chronic myeloid leukemia,5/76,0.0249370968412921,0.1528196447453545,0,0,3.192597445135932,11.78515022214837,CDK6;E2F1;E2F2;PTPN11;TGFBR1
39,KEGG_2019_Mouse,HIF-1 signaling pathway,6/104,0.0260875710385058,0.1542167879586061,0,0,2.7782217782217784,10.130219744659192,FLT1;RPS6;SLC2A1;ENO1;TEK;EIF4E
40,KEGG_2019_Mouse,Hepatitis B,8/163,0.0264555996079617,0.1542167879586061,0,0,2.346150940545441,8.521894588242622,ATF2;PCNA;CCNE2;E2F1;E2F2;HSPG2;TGFBR1;JAK1
41,KEGG_2019_Mouse,Salmonella infection,5/78,0.0275230783315884,0.1566194219345153,0,0,3.104810449187639,11.154746931101904,CDC42;PKN2;RAC1;WASF2;ACTB
42,KEGG_2019_Mouse,Epstein-Barr virus infection,10/229,0.0287730769033673,0.1599247762768555,0,0,2.0785388127853883,7.375310777581878,PDIA3;CDK6;CCNE2;E2F1;E2F2;RAC1;VIM;B2M;CD44;JAK1
43,KEGG_2019_Mouse,Tight junction,8/167,0.0299725337402977,0.1628053537257082,0,0,2.286656945487753,8.02038946005502,CDC42;PRKCI;PCNA;RAC1;ARHGEF2;PRKAB1;MYL9;ACTB
44,KEGG_2019_Mouse,Biosynthesis of unsaturated fatty acids,3/32,0.0317957563898336,0.1688707950482274,0,0,4.67816091954023,16.13227511608383,ACOT7;ELOVL6;HSD17B12
45,KEGG_2019_Mouse,SNARE interactions in vesicular transport,3/33,0.0344270125581676,0.1788707826391755,0,0,4.5219907407407405,15.234196892225317,STX17;SNAP23;SEC22B
46,KEGG_2019_Mouse,MicroRNAs in cancer,11/281,0.0443257260172074,0.2220655187711099,0,0,1.853991963661775,5.777391305769786,ZEB2;CDK6;CCNE2;STMN1;DNMT3B;E2F1;E2F2;VIM;CD44;CDC25B;MCL1
47,KEGG_2019_Mouse,Phospholipase D signaling pathway,7/149,0.0445989326402229,0.2220655187711099,0,0,2.237083717256812,6.957431817059575,RHEB;GNA12;LPAR1;TSC1;PTPN11;PLPP3;DGKZ
48,KEGG_2019_Mouse,Dilated cardiomyopathy (DCM),5/90,0.0465688071817399,0.2225988983287169,0,0,2.6648426812585497,8.172604385865231,TPM3;ATP2A2;ITGAV;ITGA6;ACTB
49,KEGG_2019_Mouse,Progesterone-mediated oocyte maturation,5/90,0.0465688071817399,0.2225988983287169,0,0,2.6648426812585497,8.172604385865231,RPS6KA1;ANAPC1;GNAI1;CDC25B;AURKA
50,KEGG_2019_Mouse,Neurotrophin signaling pathway,6/121,0.0489021402812028,0.2280037872081718,0,0,2.3654606263301914,7.138804321719346,CDC42;RIPK2;RPS6KA1;RAPGEF1;PTPN11;RAC1
51,KEGG_2019_Mouse,Morphine addiction,5/92,0.0503468891425806,0.2280037872081718,0,0,2.603314621758888,7.7808347632492385,SLC32A1;GABRA4;GNB1;GNB4;GNAI1
52,KEGG_2019_Mouse,Glutathione metabolism,4/64,0.0505615092972096,0.2280037872081718,0,0,3.017014694508894,9.00447549018656,PGD;GCLM;SRM;GSTM5
53,KEGG_2019_Mouse,mTOR signaling pathway,7/154,0.051609309444551,0.228418980689772,0,0,2.160436137071651,6.403647660985037,CLIP1;RHEB;RPS6KA1;RPS6;RRAGD;TSC1;EIF4E
54,KEGG_2019_Mouse,Platelet activation,6/125,0.055625904278653,0.2391580068824509,0,0,2.2854792266556974,6.602992390958317,GUCY1A1;PRKCI;SNAP23;TLN1;ACTB;GNAI1
55,KEGG_2019_Mouse,AMPK signaling pathway,6/126,0.0573896920410293,0.2391580068824509,0,0,2.266317016317016,6.476886036248529,RAB2A;RAB14;RHEB;TSC1;HMGCR;PRKAB1
56,KEGG_2019_Mouse,MAPK signaling pathway,11/294,0.0576558412954791,0.2391580068824509,0,0,1.7676345089672645,5.043527404005351,CDC42;ATF2;FLT1;STMN1;RPS6KA1;GNA12;KDR;RAC1;TEK;TGFBR1;CDC25B
57,KEGG_2019_Mouse,Glycolysis / Gluconeogenesis,4/67,0.0580383447664525,0.2391580068824509,0,0,2.8729053879865947,8.178160059207489,PKLR;AKR1A1;PGM2;ENO1
58,KEGG_2019_Mouse,Porphyrin and chlorophyll metabolism,3/41,0.0593182185294795,0.2402890547211118,0,0,3.568530701754386,10.080523962811265,ALAD;UROD;GUSB
59,KEGG_2019_Mouse,Steroid biosynthesis,2/19,0.0632646231970721,0.2520040824016707,0,0,5.311234886564326,14.661286707388811,DHCR24;CYP51
60,KEGG_2019_Mouse,Basal transcription factors,3/43,0.0665608435162791,0.2595754919327649,0,0,3.3897569444444446,9.185016971535292,GTF2IRD1;TAF4;GTF2I
61,KEGG_2019_Mouse,Spliceosome,6/132,0.0686710051715701,0.2595754919327649,0,0,2.157731157731157,5.779328021335313,PRPF38B;HNRNPA3;PRPF40A;SNRPB2;SRSF6;BCAS2
62,KEGG_2019_Mouse,Adipocytokine signaling pathway,4/71,0.0688722760417648,0.2595754919327649,0,0,2.700834574228625,7.226087120955816,SLC2A1;PRKCQ;PTPN11;PRKAB1
63,KEGG_2019_Mouse,T cell receptor signaling pathway,5/101,0.0695097551619119,0.2595754919327649,0,0,2.3581637596899223,6.287544145333814,VAV3;CDC42;PRKCQ;BCL10;VAV2
64,KEGG_2019_Mouse,Longevity regulating pathway,5/102,0.0718561659952668,0.2641071722644793,0,0,2.333732917765524,6.14492613054928,ATF2;RHEB;TSC1;PRKAB1;EIF4E
65,KEGG_2019_Mouse,RNA transport,7/167,0.0729333613784754,0.2641071722644793,0,0,1.9835718457943925,5.193405882098743,FXR1;POM121;NUP188;NMD3;EIF4G3;EIF4E;SRRM1
66,KEGG_2019_Mouse,Thyroid hormone synthesis,4/73,0.0746527777845226,0.2662987147835956,0,0,2.622280507078248,6.804575472692955,ATF2;HSPA5;TTF2;TTF1
67,KEGG_2019_Mouse,Mismatch repair,2/22,0.0819341443862336,0.2879744192398507,0,0,4.513856812933025,11.29294514388347,PCNA;RPA2
68,KEGG_2019_Mouse,Terpenoid backbone biosynthesis,2/23,0.0884898654216843,0.3065083744316311,0,0,4.29869130100077,10.423755747358278,ICMT;HMGCR
69,KEGG_2019_Mouse,Human papillomavirus infection,12/360,0.095743496237639,0.326895651439939,0,0,1.566560691285563,3.67528074463984,CDC42;LAMA5;PRKCI;RELN;CDK6;CCNE2;RHEB;E2F1;TSC1;ITGAV;ITGA6;JAK1
70,KEGG_2019_Mouse,Oocyte meiosis,5/116,0.1091152928576182,0.3673035914502923,0,0,2.037921642572805,4.514710165573337,CDC20;CCNE2;RPS6KA1;ANAPC1;AURKA
71,KEGG_2019_Mouse,VEGF signaling pathway,3/58,0.1320136198602516,0.4375392238414901,0,0,2.4633838383838382,4.98798321092312,CDC42;KDR;RAC1
72,KEGG_2019_Mouse,Endocytosis,9/269,0.1339735148659678,0.4375392238414901,0,0,1.568661971830986,3.153188055632288,SH3GLB1;CDC42;PRKCI;EHD4;CAPZB;WIPF1;CLTA;STAM;TGFBR1
73,KEGG_2019_Mouse,Ras signaling pathway,8/233,0.1370241657344316,0.4375392238414901,0,0,1.610408534998699,3.2008447454810693,CDC42;FLT1;GNB1;KDR;GNB4;PTPN11;RAC1;TEK
74,KEGG_2019_Mouse,Circadian rhythm,2/30,0.1380518947399782,0.4375392238414901,0,0,3.222863741339492,6.381675050050548,PRKAB1;CLOCK
75,KEGG_2019_Mouse,Chemokine signaling pathway,7/197,0.1391338117654947,0.4375392238414901,0,0,1.667793900639449,3.2894218223893072,VAV3;CDC42;GNB1;GNB4;RAC1;GNAI1;VAV2
76,KEGG_2019_Mouse,Glycerolipid metabolism,3/61,0.1470914203818707,0.4439808072802052,0,0,2.3356082375478926,4.476662593478519,AKR1A1;PLPP3;DGKZ
77,KEGG_2019_Mouse,Long-term depression,3/61,0.1470914203818707,0.4439808072802052,0,0,2.3356082375478926,4.476662593478519,GUCY1A1;GNA12;GNAI1
78,KEGG_2019_Mouse,JAK-STAT signaling pathway,6/164,0.1483954384998206,0.4439808072802052,0,0,1.7178897052314774,3.277518282970024,MPL;PTPN11;STAM;IL11RA1;MCL1;JAK1
79,KEGG_2019_Mouse,Hematopoietic cell lineage,4/94,0.1486128225205708,0.4439808072802052,0,0,2.008249548852797,3.8285487527126416,CD59A;ITGA6;CD44;IL11RA1
80,KEGG_2019_Mouse,Pentose phosphate pathway,2/32,0.1531376677877334,0.451850649398374,0,0,3.0076982294072363,5.643699014103461,PGM2;PGD
81,KEGG_2019_Mouse,Relaxin signaling pathway,5/131,0.1574310055778014,0.4578106521944319,0,0,1.7939276485788114,3.3165559888794536,ATF2;GNB1;GNB4;TGFBR1;GNAI1
82,KEGG_2019_Mouse,Starch and sucrose metabolism,2/33,0.1607964233406905,0.4578106521944319,0,0,2.9105267078894435,5.319325661140418,GYG;PGM2
83,KEGG_2019_Mouse,Prostate cancer,4/97,0.1609041622775409,0.4578106521944319,0,0,1.943167926552404,3.5500635636678077,CCNE2;LEF1;E2F1;E2F2
84,KEGG_2019_Mouse,Ribosome,6/170,0.166683962696113,0.4580267505862592,0,0,1.6545283984308374,2.964345233272388,MRPL20;RPL12;RPS6;RPLP2;RPS20;RPL22L1
85,KEGG_2019_Mouse,Pentose and glucuronate interconversions,2/34,0.1685232389858319,0.4580267505862592,0,0,2.8194284064665127,5.020504347571755,AKR1A1;GUSB
86,KEGG_2019_Mouse,Circadian entrainment,4/99,0.1692980091589295,0.4580267505862592,0,0,1.902063744046892,3.378245428373968,GUCY1A1;GNB1;GNB4;GNAI1
87,KEGG_2019_Mouse,Dopaminergic synapse,5/135,0.1715939643859335,0.4580267505862592,0,0,1.7383720930232558,3.064096832975429,ATF2;GNB1;GNB4;CLOCK;GNAI1
88,KEGG_2019_Mouse,Non-small cell lung cancer,3/66,0.1733620704391041,0.4580267505862592,0,0,2.1496913580246915,3.7670610486091034,CDK6;E2F1;E2F2
89,KEGG_2019_Mouse,Purine metabolism,5/136,0.1752098971830511,0.4580267505862592,0,0,1.7250133143973017,3.004577495126275,GUCY1A1;PKLR;GMPS;PGM2;PDE5A
90,KEGG_2019_Mouse,Base excision repair,2/35,0.1763115525269282,0.4580267505862592,0,0,2.733851214220729,4.7446060654305455,PCNA;HMGB1
91,KEGG_2019_Mouse,DNA replication,2/35,0.1763115525269282,0.4580267505862592,0,0,2.733851214220729,4.7446060654305455,PCNA;RPA2
92,KEGG_2019_Mouse,Fc epsilon RI signaling pathway,3/68,0.1842192425922967,0.4734236449414938,0,0,2.083333333333333,3.524226447626817,VAV3;RAC1;VAV2
93,KEGG_2019_Mouse,"Alanine, aspartate and glutamate metabolism",2/37,0.1920476767447121,0.4772896228561442,0,0,2.577367205542725,4.25268584176346,GAD2;ASS1
94,KEGG_2019_Mouse,Thyroid cancer,2/37,0.1920476767447121,0.4772896228561442,0,0,2.577367205542725,4.25268584176346,TPM3;LEF1
95,KEGG_2019_Mouse,Kaposi sarcoma-associated herpesvirus infection,7/216,0.1921733133004724,0.4772896228561442,0,0,1.5146894423825068,2.49826460504949,CDK6;GNB1;GNB4;E2F1;E2F2;RAC1;JAK1
96,KEGG_2019_Mouse,Apoptosis,5/141,0.1937116879374309,0.4772896228561442,0,0,1.661166210670315,2.7266122541323683,ENDOG;CTSZ;SPTAN1;ACTB;MCL1
97,KEGG_2019_Mouse,Axon guidance,6/180,0.1991192179764465,0.4856070724119462,0,0,1.558636765533317,2.515408357338188,CDC42;UNC5C;PTPN11;RAC1;MYL9;GNAI1
98,KEGG_2019_Mouse,"Parathyroid hormone synthesis, secretion and action",4/107,0.2042957476616891,0.4885030475992069,0,0,1.7536098033473746,2.7850595765074893,ATF2;GNA12;MEF2D;GNAI1
99,KEGG_2019_Mouse,Bile secretion,3/72,0.2064385263912966,0.4885030475992069,0,0,1.962157809983897,3.0957995940055647,CAR2;SLC2A1;HMGCR
100,KEGG_2019_Mouse,Melanoma,3/72,0.2064385263912966,0.4885030475992069,0,0,1.962157809983897,3.0957995940055647,CDK6;E2F1;E2F2
101,KEGG_2019_Mouse,Toxoplasmosis,4/108,0.2088136362913755,0.4892790105258702,0,0,1.7366589327146171,2.720151666408656,LAMA5;ITGA6;GNAI1;JAK1
102,KEGG_2019_Mouse,Taurine and hypotaurine metabolism,1/11,0.2149052051904662,0.4910044301047496,0,0,4.505760368663594,6.927869046164286,GAD2
103,KEGG_2019_Mouse,Nicotine addiction,2/40,0.2159631219228223,0.4910044301047496,0,0,2.373526194238483,3.6377792671792446,SLC32A1;GABRA4
104,KEGG_2019_Mouse,Breast cancer,5/147,0.216763332649318,0.4910044301047496,0,0,1.5904847690795938,2.4317703414454983,CDK6;NCOA3;LEF1;E2F1;E2F2
105,KEGG_2019_Mouse,Gastric acid secretion,3/74,0.2177676551929015,0.4910044301047496,0,0,1.9066901408450705,2.9064184737763243,CAR2;ACTB;GNAI1
106,KEGG_2019_Mouse,Glioma,3/75,0.2234800424071653,0.4911476212503652,0,0,1.8801118827160492,2.817221998282307,CDK6;E2F1;E2F2
107,KEGG_2019_Mouse,Bladder cancer,2/41,0.2239961954656477,0.4911476212503652,0,0,2.312548113933796,3.459863849304297,E2F1;E2F2
108,KEGG_2019_Mouse,Homologous recombination,2/41,0.2239961954656477,0.4911476212503652,0,0,2.312548113933796,3.459863849304297,RPA2;RAD54B
109,KEGG_2019_Mouse,Gastric cancer,5/150,0.2285980587247373,0.4922066309478579,0,0,1.557337610264635,2.298303302493462,CCNE2;LEF1;E2F1;E2F2;TGFBR1
110,KEGG_2019_Mouse,Retrograde endocannabinoid signaling,5/150,0.2285980587247373,0.4922066309478579,0,0,1.557337610264635,2.298303302493462,SLC32A1;GABRA4;GNB1;GNB4;GNAI1
111,KEGG_2019_Mouse,Viral carcinogenesis,7/229,0.2324764686318186,0.4960881785982559,0,0,1.4250336785383515,2.079076069550585,CDC20;CDC42;ATF2;CDK6;CCNE2;RAC1;JAK1
112,KEGG_2019_Mouse,Drug metabolism,4/114,0.2364814750802102,0.5001687835767278,0,0,1.641425859523307,2.366747987919582,DUT;GMPS;GUSB;GSTM5
113,KEGG_2019_Mouse,Nucleotide excision repair,2/43,0.2401241802356588,0.5034182375116006,0,0,2.199515574832423,3.137826877478604,PCNA;RPA2
114,KEGG_2019_Mouse,Oxytocin signaling pathway,5/154,0.2446602365784808,0.5084677960196253,0,0,1.5152177306071484,2.133252042515872,GUCY1A1;PRKAB1;MYL9;ACTB;GNAI1
115,KEGG_2019_Mouse,Natural killer cell mediated cytotoxicity,4/118,0.2553859265608195,0.5261830728278954,0,0,1.5835063296291774,2.161453583722924,VAV3;PTPN11;RAC1;VAV2
116,KEGG_2019_Mouse,Hippo signaling pathway,5/159,0.2651356230590129,0.541601828300035,0,0,1.465644820295983,1.945663723060543,PRKCI;BMP2;LEF1;ACTB;TGFBR1
117,KEGG_2019_Mouse,Cocaine addiction,2/48,0.2805963936650817,0.561455897568623,0,0,1.959935736519731,2.490760740231553,ATF2;GNAI1
118,KEGG_2019_Mouse,Sphingolipid metabolism,2/48,0.2805963936650817,0.561455897568623,0,0,1.959935736519731,2.490760740231553,UGCG;PLPP3
119,KEGG_2019_Mouse,PPAR signaling pathway,3/85,0.2819025427122793,0.561455897568623,0,0,1.6499830623306233,2.089198424267099,FABP5;UBC;ACADM
120,KEGG_2019_Mouse,Gap junction,3/86,0.2878347817119988,0.5685331638774193,0,0,1.6300200803212852,2.02997588745899,GUCY1A1;LPAR1;GNAI1
121,KEGG_2019_Mouse,Viral myocarditis,3/87,0.2937765107198142,0.5755130005084885,0,0,1.6105324074074074,1.972799074005786,RAC1;EIF4G3;ACTB
122,KEGG_2019_Mouse,Arginine and proline metabolism,2/50,0.2967618665404739,0.5766348463672623,0,0,1.8780792917628943,2.281538160066264,SMOX;SRM
123,KEGG_2019_Mouse,Colorectal cancer,3/88,0.2997261101250343,0.5776979058055098,0,0,1.591503267973856,1.917580305075441,LEF1;RAC1;TGFBR1
124,KEGG_2019_Mouse,cAMP signaling pathway,6/211,0.3111934979263734,0.5911315917761354,0,0,1.320825515947467,1.541852960292808,VAV3;ATP2A2;RAC1;MYL9;GNAI1;VAV2
125,KEGG_2019_Mouse,Antigen processing and presentation,3/90,0.3116425965012262,0.5911315917761354,0,0,1.554757343550447,1.8126888999469968,PDIA3;HSPA5;B2M
126,KEGG_2019_Mouse,TGF-beta signaling pathway,3/91,0.3176063996750854,0.5977002324594127,0,0,1.5370107323232325,1.7628627776980703,BMP2;E2F5;TGFBR1
127,KEGG_2019_Mouse,Serotonergic synapse,4/132,0.3234513068017341,0.6039442369188629,0,0,1.4092952436194897,1.5906809785416514,APP;GNB1;GNB4;GNAI1
128,KEGG_2019_Mouse,Necroptosis,5/176,0.3370528281660505,0.6244622165246982,0,0,1.318781449748402,1.434195400618956,H2AFZ;TRPM7;HMGB1;PPID;JAK1
129,KEGG_2019_Mouse,Arginine biosynthesis,1/19,0.3416375986831081,0.6280875852712525,0,0,2.5021761392729136,2.6873490757355065,ASS1
130,KEGG_2019_Mouse,Ubiquitin mediated proteolysis,4/138,0.3530810712530032,0.6414481633494533,0,0,1.345776915884614,1.401031265745566,CDC20;FBXW7;UBE2D3;ANAPC1
131,KEGG_2019_Mouse,Phagosome,5/180,0.3542726257829617,0.6414481633494533,0,0,1.2883720930232558,1.336928947058431,STX12;ITGAV;RAC1;SEC22B;ACTB
132,KEGG_2019_Mouse,Vascular smooth muscle contraction,4/140,0.3629680080086114,0.6522507813087078,0,0,1.325849597379555,1.343669786033502,GUCY1A1;GNA12;PRKCQ;MYL9
133,KEGG_2019_Mouse,Lysine degradation,2/59,0.368471114369609,0.6550232480546858,0,0,1.5808111502775417,1.5782707195459014,SETD7;ASH1L
134,KEGG_2019_Mouse,Glycosaminoglycan degradation,1/21,0.3699922112442786,0.6550232480546858,0,0,2.2517281105990783,2.2388331938473214,GUSB
135,KEGG_2019_Mouse,AGE-RAGE signaling pathway in diabetic complications,3/101,0.3771070287155511,0.6597590866811245,0,0,1.3794642857142858,1.3452897630917755,CDC42;RAC1;TGFBR1
136,KEGG_2019_Mouse,Glucagon signaling pathway,3/102,0.383014265072117,0.6597590866811245,0,0,1.365460157126824,1.3104089612483143,ATF2;SLC2A1;PRKAB1
137,KEGG_2019_Mouse,Th17 cell differentiation,3/102,0.383014265072117,0.6597590866811245,0,0,1.365460157126824,1.3104089612483143,PRKCQ;TGFBR1;JAK1
138,KEGG_2019_Mouse,Proximal tubule bicarbonate reclamation,1/22,0.3837092596178925,0.6597590866811245,0,0,2.144393241167435,2.054050274672564,CAR2
139,KEGG_2019_Mouse,Basal cell carcinoma,2/63,0.3994596868059498,0.6772793847611988,0,0,1.4768485215613525,1.3552188630975288,BMP2;LEF1
140,KEGG_2019_Mouse,Pancreatic secretion,3/105,0.40065549527283,0.6772793847611988,0,0,1.3250953159041394,1.2120028498294384,CAR2;ATP2A2;RAC1
141,KEGG_2019_Mouse,Adrenergic signaling in cardiomyocytes,4/148,0.4024003039166955,0.6772793847611988,0,0,1.2516756896107244,1.1394102746697563,ATF2;TPM3;ATP2A2;GNAI1
142,KEGG_2019_Mouse,Human immunodeficiency virus 1 infection,6/238,0.4154733789121292,0.6880020521601622,0,0,1.1654810706534844,1.0236848403371486,PDIA3;GNB1;GNB4;RAC1;B2M;GNAI1
143,KEGG_2019_Mouse,Non-alcoholic fatty liver disease (NAFLD),4/151,0.417087818142207,0.6880020521601622,0,0,1.2259418848745995,1.0720352824752135,CDC42;PKLR;RAC1;PRKAB1
144,KEGG_2019_Mouse,Leishmaniasis,2/67,0.4297200167560791,0.6880020521601622,0,0,1.3856812933025404,1.1703760824814498,MARCKSL1;JAK1
145,KEGG_2019_Mouse,Folate biosynthesis,1/26,0.4356614676054343,0.6880020521601622,0,0,1.8009216589861752,1.4963674148509591,QDPR
146,KEGG_2019_Mouse,Alcoholism,5/199,0.4360062983713391,0.6880020521601622,0,0,1.16105250539439,0.9637880475644562,ATF2;H2AFZ;GNB1;GNB4;GNAI1
147,KEGG_2019_Mouse,Acute myeloid leukemia,2/69,0.444545857463593,0.6880020521601622,0,0,1.3441797938712905,1.0897293318700911,LEF1;RUNX1T1
148,KEGG_2019_Mouse,Cortisol synthesis and secretion,2/69,0.444545857463593,0.6880020521601622,0,0,1.3441797938712905,1.0897293318700911,HSD3B6;ATF2
149,KEGG_2019_Mouse,Cholinergic synapse,3/113,0.4469256209744158,0.6880020521601622,0,0,1.228219696969697,0.989162815563328,GNB1;GNB4;GNAI1
150,KEGG_2019_Mouse,Butanoate metabolism,1/27,0.447951783490829,0.6880020521601622,0,0,1.7315668202764978,1.390568809653446,GAD2
151,KEGG_2019_Mouse,Collecting duct acid secretion,1/27,0.447951783490829,0.6880020521601622,0,0,1.7315668202764978,1.390568809653446,CAR2
152,KEGG_2019_Mouse,Maturity onset diabetes of the young,1/27,0.447951783490829,0.6880020521601622,0,0,1.7315668202764978,1.390568809653446,PKLR
153,KEGG_2019_Mouse,Phototransduction,1/27,0.447951783490829,0.6880020521601622,0,0,1.7315668202764978,1.390568809653446,GNB1
154,KEGG_2019_Mouse,Glutamatergic synapse,3/114,0.4526132984546247,0.6880020521601622,0,0,1.217092092092092,0.9648097913968682,GNB1;GNB4;GNAI1
155,KEGG_2019_Mouse,Ribosome biogenesis in eukaryotes,3/115,0.4582767770799068,0.6880020521601622,0,0,1.2061631944444444,0.9411473821953584,NOP56;NMD3;MDN1
156,KEGG_2019_Mouse,p53 signaling pathway,2/71,0.4591549529180577,0.6880020521601622,0,0,1.30508417846504,1.0158351586590486,CDK6;CCNE2
157,KEGG_2019_Mouse,Protein export,1/28,0.4599750387768001,0.6880020521601622,0,0,1.6673493770267964,1.2948352721301588,HSPA5
158,KEGG_2019_Mouse,Hepatitis C,4/160,0.4605871478896483,0.6880020521601622,0,0,1.154679040989946,0.8951686156807954,CDK6;E2F1;E2F2;JAK1
159,KEGG_2019_Mouse,Wnt signaling pathway,4/160,0.4605871478896483,0.6880020521601622,0,0,1.154679040989946,0.8951686156807954,CTNNBIP1;LEF1;RAC1;LGR4
160,KEGG_2019_Mouse,Propanoate metabolism,1/31,0.494499717531361,0.727680308802328,0,0,1.500384024577573,1.0565834821585691,ACADM
161,KEGG_2019_Mouse,Renin secretion,2/76,0.4946743845198793,0.727680308802328,0,0,1.2165907246738656,0.8563041238046908,GUCY1A1;GNAI1
162,KEGG_2019_Mouse,Synaptic vesicle cycle,2/77,0.5015992806536564,0.727680308802328,0,0,1.2003079291762897,0.82815692540345,SLC32A1;CLTA
163,KEGG_2019_Mouse,Galactose metabolism,1/32,0.5055113912372797,0.727680308802328,0,0,1.4519102125761856,0.990470941768184,PGM2
164,KEGG_2019_Mouse,Lysosome,3/124,0.5080391550767444,0.727680308802328,0,0,1.1159320477502297,0.7557055642723369,CTSZ;CLTA;GUSB
165,KEGG_2019_Mouse,Sphingolipid signaling pathway,3/124,0.5080391550767444,0.727680308802328,0,0,1.1159320477502297,0.7557055642723369,GNA12;RAC1;GNAI1
166,KEGG_2019_Mouse,Cardiac muscle contraction,2/78,0.508462809916271,0.727680308802328,0,0,1.1844536282970706,0.8011208498510052,TPM3;ATP2A2
167,KEGG_2019_Mouse,Prion diseases,1/34,0.5268219195969013,0.7486503887314387,0,0,1.3637760089372992,0.8740340899605994,HSPA5
168,KEGG_2019_Mouse,Osteoclast differentiation,3/128,0.5293804004000551,0.7486503887314387,0,0,1.08,0.6869318531368589,RAC1;TGFBR1;JAK1
169,KEGG_2019_Mouse,Rheumatoid arthritis,2/84,0.5483248241433599,0.768988274671936,0,0,1.0974483185940405,0.6594428918718849,FLT1;TEK
170,KEGG_2019_Mouse,FoxO signaling pathway,3/132,0.5501966316690421,0.768988274671936,0,0,1.0462962962962965,0.6251406429168735,SETD7;PRKAB1;TGFBR1
171,KEGG_2019_Mouse,Estrogen signaling pathway,3/134,0.5603993891847099,0.7704892571849185,0,0,1.0302162849872774,0.5966039729548949,ATF2;NCOA3;GNAI1
172,KEGG_2019_Mouse,Insulin secretion,2/86,0.5610996268583149,0.7704892571849185,0,0,1.071208622016936,0.619005187783254,ATF2;SLC2A1
173,KEGG_2019_Mouse,Transcriptional misregulation in cancer,4/183,0.5656532529456223,0.7704892571849185,0,0,1.0051199626696392,0.5726912375074028,FLT1;LMO2;MLLT3;RUNX1T1
174,KEGG_2019_Mouse,Pyruvate metabolism,1/38,0.5667331452550399,0.7704892571849185,0,0,1.216091667704571,0.6905779979059194,PKLR
175,KEGG_2019_Mouse,Th1 and Th2 cell differentiation,2/87,0.5673895785127433,0.7704892571849185,0,0,1.0585518271973915,0.5998909785585831,PRKCQ;JAK1
176,KEGG_2019_Mouse,Complement and coagulation cascades,2/88,0.5736143062875984,0.7730009971470805,0,0,1.046189376443418,0.5814700140827861,CD59A;TFPI
177,KEGG_2019_Mouse,Steroid hormone biosynthesis,2/89,0.579773665777512,0.7730009971470805,0,0,1.0341111199596509,0.5637120508752416,HSD3B6;HSD17B12
178,KEGG_2019_Mouse,Fat digestion and absorption,1/40,0.5854107970026007,0.7730009971470805,0,0,1.1536098310291858,0.617690533455073,PLPP3
179,KEGG_2019_Mouse,Ferroptosis,1/40,0.5854107970026007,0.7730009971470805,0,0,1.1536098310291858,0.617690533455073,GCLM
180,KEGG_2019_Mouse,"Glycine, serine and threonine metabolism",1/40,0.5854107970026007,0.7730009971470805,0,0,1.1536098310291858,0.617690533455073,PHGDH
181,KEGG_2019_Mouse,Measles,3/144,0.6092553208166334,0.7991895201782995,0,0,0.9566587864460204,0.4740415080347812,CDK6;CCNE2;JAK1
182,KEGG_2019_Mouse,Vasopressin-regulated water reabsorption,1/43,0.6119317246553507,0.7991895201782995,0,0,1.0710445468509984,0.5260269962357882,DYNLL1
183,KEGG_2019_Mouse,Mineral absorption,1/44,0.6203903678403996,0.8023348086902327,0,0,1.0460829493087558,0.4994066672358012,TRPM7
184,KEGG_2019_Mouse,mRNA surveillance pathway,2/96,0.6210541406179626,0.8023348086902327,0,0,0.9567588816274384,0.4557396725134101,SSU72;SRRM1
185,KEGG_2019_Mouse,Glycerophospholipid metabolism,2/97,0.6266894892391226,0.8034810042594219,0,0,0.9466391151087882,0.4423683335488525,PLPP3;DGKZ
186,KEGG_2019_Mouse,Glycosphingolipid biosynthesis,1/45,0.6286650535418908,0.8034810042594219,0,0,1.022255969836615,0.4744869272622515,GGTA1
187,KEGG_2019_Mouse,Melanogenesis,2/100,0.643205155432573,0.8130961956162771,0,0,0.9175189706367536,0.4048933649105015,LEF1;GNAI1
188,KEGG_2019_Mouse,Ether lipid metabolism,1/47,0.64467843272471,0.8130961956162771,0,0,0.977709877780004,0.4292181956208633,PLPP3
189,KEGG_2019_Mouse,Type II diabetes mellitus,1/48,0.6524248520872615,0.8130961956162771,0,0,0.9568585155407392,0.4086353428041462,PKLR
190,KEGG_2019_Mouse,Aldosterone synthesis and secretion,2/102,0.6538921979635521,0.8130961956162771,0,0,0.8990762124711317,0.38193906168224,HSD3B6;ATF2
191,KEGG_2019_Mouse,NF-kappa B signaling pathway,2/102,0.6538921979635521,0.8130961956162771,0,0,0.8990762124711317,0.38193906168224,PRKCQ;BCL10
192,KEGG_2019_Mouse,Chagas disease (American trypanosomiasis),2/103,0.6591393886447487,0.8130961956162771,0,0,0.8901287357373151,0.3710236834544125,TGFBR1;GNAI1
193,KEGG_2019_Mouse,Amino sugar and nucleotide sugar metabolism,1/49,0.6600027696634215,0.8130961956162771,0,0,0.936875960061444,0.3892824989279541,PGM2
194,KEGG_2019_Mouse,Fatty acid degradation,1/50,0.6674158422112143,0.8138387055534706,0,0,0.9177090190915076,0.3710682779345121,ACADM
195,KEGG_2019_Mouse,N-Glycan biosynthesis,1/50,0.6674158422112143,0.8138387055534706,0,0,0.9177090190915076,0.3710682779345121,MAN1C1
196,KEGG_2019_Mouse,Fanconi anemia pathway,1/51,0.6746676478464924,0.8185054204838156,0,0,0.8993087557603686,0.3539095457742567,RPA2
197,KEGG_2019_Mouse,Amyotrophic lateral sclerosis (ALS),1/52,0.6817616866356547,0.8229345611410175,0,0,0.8816300713833921,0.337730541238493,RAC1
198,KEGG_2019_Mouse,Endocrine and other factor-regulated calcium reabsorption,1/55,0.7021310791960201,0.8286859534338131,0,0,0.8325226147806793,0.2944092763113607,CLTA
199,KEGG_2019_Mouse,C-type lectin receptor signaling pathway,2/112,0.7035282812863631,0.8286859534338131,0,0,0.8169221079151795,0.2872683738289063,PTPN11;BCL10
200,KEGG_2019_Mouse,Regulation of lipolysis in adipocytes,1/56,0.7086275630077271,0.8286859534338131,0,0,0.8173439463762044,0.281513843592505,GNAI1
201,KEGG_2019_Mouse,"Valine, leucine and isoleucine degradation",1/56,0.7086275630077271,0.8286859534338131,0,0,0.8173439463762044,0.281513843592505,ACADM
202,KEGG_2019_Mouse,Influenza A,3/168,0.7110376648811598,0.8286859534338131,0,0,0.8164983164983165,0.2784503196831896,ATF2;ACTB;JAK1
203,KEGG_2019_Mouse,Ovarian steroidogenesis,1/57,0.7149826771262253,0.8286859534338131,0,0,0.8027073732718893,0.2693058870158476,HSD3B6
204,KEGG_2019_Mouse,Cell adhesion molecules (CAMs),3/170,0.7185221455740521,0.8286859534338131,0,0,0.8066367265469062,0.2666408296317242,ITGAV;ITGA6;PTPRF
205,KEGG_2019_Mouse,Endometrial cancer,1/58,0.7211994908545319,0.8286859534338131,0,0,0.7885843641361469,0.2577405142533454,LEF1
206,KEGG_2019_Mouse,Legionellosis,1/58,0.7211994908545319,0.8286859534338131,0,0,0.7885843641361469,0.2577405142533454,SEC22B
207,KEGG_2019_Mouse,Pyrimidine metabolism,1/58,0.7211994908545319,0.8286859534338131,0,0,0.7885843641361469,0.2577405142533454,DUT
208,KEGG_2019_Mouse,Herpes simplex virus 1 infection,8/433,0.7283289573817553,0.8328737838001892,0,0,0.8437525830004132,0.2674716514541606,PDIA3;RHEB;PTPN11;TSC1;SRSF6;ZFP982;B2M;JAK1
209,KEGG_2019_Mouse,Tuberculosis,3/178,0.7469607844868588,0.8498793656050105,0,0,0.7694444444444445,0.2244797170589351,RIPK2;BCL10;JAK1
210,KEGG_2019_Mouse,Mitophagy,1/63,0.750311908546683,0.8498793656050105,0,0,0.7248030325553738,0.2082114715058012,E2F1
211,KEGG_2019_Mouse,Central carbon metabolism in cancer,1/64,0.7557597529275067,0.8520121742909156,0,0,0.7132616487455197,0.1997359008877131,SLC2A1
212,KEGG_2019_Mouse,Cytokine-cytokine receptor interaction,5/292,0.7642749418383877,0.8558235116658482,0,0,0.7810550198525241,0.2099692113118604,BMP2;TNFRSF9;MPL;IL11RA1;TGFBR1
213,KEGG_2019_Mouse,Metabolism of xenobiotics by cytochrome P450,1/66,0.7663022238346925,0.8558235116658482,0,0,0.6912442396313364,0.1839944508996149,GSTM5
214,KEGG_2019_Mouse,Long-term potentiation,1/67,0.771401946595506,0.8575119313317486,0,0,0.6807359307359307,0.1766820902973537,RPS6KA1
215,KEGG_2019_Mouse,Amphetamine addiction,1/68,0.7763906331252751,0.8590618579487997,0,0,0.6705413027030744,0.1697136632508905,ATF2
216,KEGG_2019_Mouse,Type I diabetes mellitus,1/69,0.7812706956677684,0.8604778629704914,0,0,0.6606465166711846,0.1630697499957866,GAD2
217,KEGG_2019_Mouse,Signaling pathways regulating pluripotency of stem cells,2/137,0.8021100891951856,0.8793775748516025,0,0,0.6647848772560089,0.1465913225317359,RIF1;JAK1
218,KEGG_2019_Mouse,Pertussis,1/76,0.8125815797853153,0.886789943236029,0,0,0.5987711213517665,0.1242683381559269,GNAI1
219,KEGG_2019_Mouse,Salivary secretion,1/78,0.8206761719792331,0.8878342091800108,0,0,0.5831587767071638,0.1152477321049662,GUCY1A1
220,KEGG_2019_Mouse,Systemic lupus erythematosus,2/143,0.8209680344300518,0.8878342091800108,0,0,0.6362996085368451,0.1255235270197723,SSB;H2AFZ
221,KEGG_2019_Mouse,NOD-like receptor signaling pathway,3/205,0.8262717072005968,0.8895447658601021,0,0,0.6656696919691969,0.1270308231798502,RIPK2;TRPM7;JAK1
222,KEGG_2019_Mouse,RNA degradation,1/83,0.8394191138712849,0.8993722214277464,0,0,0.5474598179161515,0.0958301900347087,ENO1
223,KEGG_2019_Mouse,Peroxisome,1/84,0.8429262661080134,0.8993722214277464,0,0,0.5408361556826384,0.0924158058332,PRDX1
224,KEGG_2019_Mouse,Taste transduction,1/88,0.8562070483000901,0.9094821535276512,0,0,0.5158641877218073,0.0800843315555586,GABRA4
225,KEGG_2019_Mouse,GnRH signaling pathway,1/90,0.8624211387385825,0.91202943432974,0,0,0.5042199554704085,0.0746303860261302,CDC42
226,KEGG_2019_Mouse,Chemical carcinogenesis,1/94,0.8740569724755507,0.9202626274081788,0,0,0.4824339725484367,0.0649403017472521,GSTM5
227,KEGG_2019_Mouse,Phosphatidylinositol signaling system,1/98,0.8847107512493909,0.9259742940812212,0,0,0.4624447717231222,0.0566469513296483,DGKZ
228,KEGG_2019_Mouse,Toll-like receptor signaling pathway,1/99,0.8872305997681993,0.9259742940812212,0,0,0.4577024358130349,0.0547642581375768,RAC1
229,KEGG_2019_Mouse,Alzheimer disease,2/175,0.8967679875770453,0.9318589088300602,0,0,0.5177482011507295,0.0564128624194112,APP;ATP2A2
230,KEGG_2019_Mouse,Amoebiasis,1/106,0.9033960312486454,0.934682473889291,0,0,0.4270353302611367,0.0433843336311102,LAMA5
231,KEGG_2019_Mouse,TNF signaling pathway,1/110,0.9115726813815688,0.9390770295267022,0,0,0.4112797530968587,0.0380779040263544,ATF2
232,KEGG_2019_Mouse,Huntington disease,2/192,0.9236789595773858,0.9474646838583486,0,0,0.4710100887322231,0.0373938272733214,CLTA;TAF4
233,KEGG_2019_Mouse,Inflammatory mediator regulation of TRP channels,1/127,0.9392894421916734,0.9593597294179912,0,0,0.355478750640041,0.0222642036743689,PRKCQ
234,KEGG_2019_Mouse,Oxidative phosphorylation,1/134,0.9480035737835416,0.9641398048266658,0,0,0.3366480717923842,0.0179759994192232,COX17
235,KEGG_2019_Mouse,Parkinson disease,1/144,0.9583319505633376,0.9705141363755836,0,0,0.3129451193967323,0.0133192751616127,GNAI1
236,KEGG_2019_Mouse,Neuroactive ligand-receptor interaction,3/348,0.9823666290753116,0.9887749838496598,0,0,0.3868760064412238,0.0068827914632163,GABRA4;LPAR1;APLNR
237,KEGG_2019_Mouse,Calcium signaling pathway,1/189,0.984637850026021,0.9887749838496598,0,0,0.2374865182861064,0.0036766167459439,ATP2A2
238,KEGG_2019_Mouse,Olfactory transduction,1/1133,0.9999955336948136,0.9999955336948136,0,0,0.037519744019801,1.6757500153141518e-07,GNB1
